Correction of nonsuppressible responder cells by colchicine in familial Mediterranean fever
β Scribed by David Ilfeld; Shulamit Weil; Oded Kuperman
- Publisher
- John Wiley and Sons
- Year
- 1982
- Tongue
- English
- Weight
- 230 KB
- Volume
- 25
- Category
- Article
- ISSN
- 0004-3591
No coin nor oath required. For personal study only.
β¦ Synopsis
BEFORE 2 4 6-12 months Figure 3. Level of C4 in SLE patients before and during levamisole treatment.
observations correspond to several studies previously reported, which also contradict the findings to Hadidi et al.
π SIMILAR VOLUMES
In order to demonstrate the effect of prophylactic colchicine treatment on the natural history of familial Mediterranean fever (FMF), a family is presented with 6 out of 9 siblings affected by FMF. Each patient represents a different stage of the amyloidotic kidney disease of FMF a n d the effect of
## Abstract We tested the clinical and immunoregulatory effects of peritoneal dialysis and hemodialysis on a patient with familial Mediterranean fever (FMF), amyloidosis, and chronic renal failure. His frequency of FMF attacks during maintenance hemodialysis (no attacks in 21 months) was significan
In their recent article, Cazeneuve et al investigated the diagnostic value of MEFV gene analysis in populations classically affected with familial Mediterranean fever (FMF) (1). They concluded that a search for very few mutations is highly sensitive in the molecular diagnosis of MEFV-related FMF.